Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

    Publikation: Bidrag til tidsskriftKonferenceartikelForskningpeer review

  1. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Peptid-receptor radionuklid terapi til patienter med neuroendokrine neoplasma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Jaume Capdevila
  • Lisa Bodei
  • Philippa Davies
  • Vera Gorbounova
  • Robert T Jensen
  • Ulrich P Knigge
  • Guenter J Krejs
  • Eric Krenning
  • Juan Manuel O'Connor
  • Marc Peeters
  • Guido Rindi
  • Ramon Salazar
  • Marie-Pierre Vullierme
  • Marianne E Pavel
  • ENETS 2016 Munich Advisory Board Participants
Vis graf over relationer

Unmet medical needs are not infrequent in oncology, and these needs are usually of higher magnitude in rare cancers. The field of neuroendocrine neoplasms (NENs) has evolved rapidly during the last decade, and, currently, a new WHO classification is being implemented and several treatment options are available in the metastatic setting after the results of prospective phase III clinical trials. However, several questions are still unanswered, and decisions in our daily clinical practice should be made with limited evidence. In the 2016 meeting of the advisory board of the European Neuroendocrine Tumor Society (ENETS), the main unmet medical needs in the metastatic NENs setting were deeply discussed, and several proposals to try to solve them are presented in this article, including biomarkers, imaging, and therapy.

OriginalsprogEngelsk
TidsskriftNeuroendocrinology
Vol/bind108
Udgave nummer1
Sider (fra-til)18-25
Antal sider8
ISSN0028-3835
DOI
StatusUdgivet - 1 jan. 2019

ID: 59437533